PharmaCyte Biotech Inc (PMCB) — Cash Flow-to-Debt Ratio
PharmaCyte Biotech Inc (PMCB) has a Cash Flow-to-Debt Ratio of -0.05x as of January 2026, meaning its operating cash flow of $-786.85K could theoretically repay 0% of its total liabilities ($16.47 Million) in one year. See PMCB free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
PharmaCyte Biotech Inc Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for PharmaCyte Biotech Inc across 24 annual periods. Also explore PharmaCyte Biotech Inc annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for PharmaCyte Biotech Inc (2002–2025)
Year-by-year debt coverage analysis for PharmaCyte Biotech Inc. For market capitalisation and broader financial context, see PharmaCyte Biotech Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.91x | $-2.98 Million | $3.28 Million | ▼ -761.2% |
| 2024 | -0.11x | $-2.15 Million | $20.39 Million | ▲ +98.4% |
| 2023 | -6.47x | $-3.79 Million | $586.58K | ▼ -10.6% |
| 2022 | -5.85x | $-4.12 Million | $704.37K | ▼ -27.2% |
| 2021 | -4.60x | $-3.33 Million | $724.78K | ▼ -111.8% |
| 2020 | -2.17x | $-2.34 Million | $1.08 Million | ▲ +44.0% |
| 2019 | -3.87x | $-2.88 Million | $742.85K | ▲ +50.9% |
| 2018 | -7.89x | $-5.08 Million | $644.17K | ▼ -37.0% |
| 2017 | -5.76x | $-3.34 Million | $580.25K | ▲ +15.6% |
| 2016 | -6.82x | $-4.35 Million | $637.64K | ▼ -200.8% |
| 2015 | -2.27x | $-4.56 Million | $2.01 Million | ▲ +45.8% |
| 2014 | -4.18x | $-1.56 Million | $373.67K | ▼ -3968.3% |
| 2013 | -0.10x | $-390.43K | $3.80 Million | ▼ -73.1% |
| 2012 | -0.06x | $-259.29K | $4.37 Million | ▼ -4.6% |
| 2011 | -0.06x | $-225.23K | $3.97 Million | ▲ +81.6% |
| 2010 | -0.31x | $-974.06K | $3.15 Million | ▲ +25.7% |
| 2009 | -0.42x | $-1.19 Million | $2.85 Million | ▲ +93.7% |
| 2008 | -6.60x | $-1.19 Million | $180.56K | ▼ -122.9% |
| 2007 | -2.96x | $-351.60K | $118.81K | ▼ -99.8% |
| 2006 | -1.48x | $-1.07 Million | $723.89K | ▲ +13.6% |
| 2005 | -1.71x | $-2.80 Million | $1.63 Million | ▼ -155.4% |
| 2004 | -0.67x | $-221.03K | $329.13K | ▲ +95.5% |
| 2003 | -14.84x | $-37.46K | $2.52K | ▼ -574.6% |
| 2002 | -2.20x | $-21.99K | $10.00K | — |